CH624963A5 - - Google Patents
Download PDFInfo
- Publication number
- CH624963A5 CH624963A5 CH977776A CH977776A CH624963A5 CH 624963 A5 CH624963 A5 CH 624963A5 CH 977776 A CH977776 A CH 977776A CH 977776 A CH977776 A CH 977776A CH 624963 A5 CH624963 A5 CH 624963A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- compounds
- carbon atoms
- hydrogen
- sodium
- Prior art date
Links
- -1 alkenyl radical Chemical class 0.000 description 33
- 150000001875 compounds Chemical class 0.000 description 32
- 238000000034 method Methods 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 239000000460 chlorine Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 229910001415 sodium ion Inorganic materials 0.000 description 7
- 230000000875 corresponding effect Effects 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 150000002431 hydrogen Chemical group 0.000 description 5
- 239000000375 suspending agent Substances 0.000 description 5
- JBFBFCTUNDSIRH-UHFFFAOYSA-N (2-formylphenoxy)boronic acid Chemical compound OB(O)OC1=CC=CC=C1C=O JBFBFCTUNDSIRH-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 3
- 229910000039 hydrogen halide Inorganic materials 0.000 description 3
- 239000012433 hydrogen halide Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910001414 potassium ion Inorganic materials 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DGUWACLYDSWXRZ-UHFFFAOYSA-N (2-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1C=O DGUWACLYDSWXRZ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ZOZQKKYSAGUTAT-UHFFFAOYSA-N 2-chlorosulfonyloxypropane Chemical compound CC(C)OS(Cl)(=O)=O ZOZQKKYSAGUTAT-UHFFFAOYSA-N 0.000 description 1
- UJDRKBHTJBEDDX-UHFFFAOYSA-N 3-hydroxy-2h-diazaborinine Chemical class OB1NN=CC=C1 UJDRKBHTJBEDDX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- KQDDQXNVESLJNO-UHFFFAOYSA-N chloromethanesulfonyl chloride Chemical compound ClCS(Cl)(=O)=O KQDDQXNVESLJNO-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004957 naphthylene group Chemical group 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- QMMOXUPEWRXHJS-UHFFFAOYSA-N pentene-2 Natural products CCC=CC QMMOXUPEWRXHJS-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000005556 thienylene group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752533918 DE2533918A1 (de) | 1975-07-30 | 1975-07-30 | Neue derivate des 1-hydroxy-benzo- 2,3,1-diazaborins und verfahren zu deren herstellung |
| DE19762620777 DE2620777A1 (de) | 1976-05-11 | 1976-05-11 | Neue derivate des 1-hydroxy-benzo-2,3, 1-diazaborins und verfahren zu deren herstellung |
| DE19762620776 DE2620776A1 (de) | 1976-05-11 | 1976-05-11 | Neue derivate des 1-hydroxy-benzo-2,3,1- diazaborins und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH624963A5 true CH624963A5 (fr) | 1981-08-31 |
Family
ID=27186467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH977776A CH624963A5 (fr) | 1975-07-30 | 1976-07-30 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4112077A (fr) |
| JP (1) | JPS5236676A (fr) |
| AT (1) | AT342074B (fr) |
| AU (1) | AU502943B2 (fr) |
| CA (1) | CA1056398A (fr) |
| CH (1) | CH624963A5 (fr) |
| DK (1) | DK140554B (fr) |
| ES (1) | ES450211A1 (fr) |
| FR (1) | FR2319372A1 (fr) |
| GB (1) | GB1534024A (fr) |
| IE (1) | IE43238B1 (fr) |
| NL (1) | NL7606518A (fr) |
| SE (1) | SE7606511L (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4199573A (en) * | 1976-07-26 | 1980-04-22 | Grunenthal Gmbh | Diazaborines and drug compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3714206A (en) * | 1968-12-02 | 1973-01-30 | Gruenenthal Chemie | Benzo-2,3,1-diazaborines |
-
1976
- 1976-05-24 AT AT376876A patent/AT342074B/de not_active IP Right Cessation
- 1976-06-09 SE SE7606511A patent/SE7606511L/ not_active Application Discontinuation
- 1976-06-11 GB GB24281/76A patent/GB1534024A/en not_active Expired
- 1976-06-15 IE IE1291/76A patent/IE43238B1/en unknown
- 1976-06-16 NL NL7606518A patent/NL7606518A/xx not_active Application Discontinuation
- 1976-06-21 AU AU15086/76A patent/AU502943B2/en not_active Expired
- 1976-07-23 JP JP51087365A patent/JPS5236676A/ja active Pending
- 1976-07-26 US US05/708,361 patent/US4112077A/en not_active Expired - Lifetime
- 1976-07-27 ES ES450211A patent/ES450211A1/es not_active Expired
- 1976-07-28 CA CA258,003A patent/CA1056398A/fr not_active Expired
- 1976-07-29 FR FR7623196A patent/FR2319372A1/fr active Granted
- 1976-07-29 DK DK341376AA patent/DK140554B/da unknown
- 1976-07-30 CH CH977776A patent/CH624963A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE43238B1 (en) | 1981-01-14 |
| JPS5236676A (en) | 1977-03-22 |
| DK140554B (da) | 1979-10-01 |
| SE7606511L (sv) | 1977-01-31 |
| US4112077A (en) | 1978-09-05 |
| DK341376A (fr) | 1977-01-31 |
| FR2319372B1 (fr) | 1979-03-02 |
| CA1056398A (fr) | 1979-06-12 |
| AT342074B (de) | 1978-03-10 |
| IE43238L (en) | 1977-01-30 |
| AU1508676A (en) | 1978-01-05 |
| ES450211A1 (es) | 1977-08-16 |
| AU502943B2 (en) | 1979-08-16 |
| ATA376876A (de) | 1977-07-15 |
| FR2319372A1 (fr) | 1977-02-25 |
| NL7606518A (nl) | 1977-02-01 |
| DK140554C (fr) | 1980-02-18 |
| GB1534024A (en) | 1978-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2812625A1 (de) | Oximderivate der 3-acetoxymethyl-7- aminothiazolyl-acetamido-cephalosporansaeure, ihre herstellung und pharmazeutische mittel | |
| DD148055A5 (de) | Verfahren zur herstellung von o-substituierten derivaten des(+)-cyanidan-3-ols | |
| DE2515629A1 (de) | Paromomycin-derivate, verfahren zu ihrer herstellung und arzneimittel | |
| DE2405395C2 (de) | 2,2'-Azine von 2,4-Thiazolidindionen | |
| CH651563A5 (de) | Hydroxyimino-oktahydro-indolo(2,3-a)chinolizin-derivate sowie verfahren zu ihrer herstellung. | |
| CH380746A (de) | Verfahren zur Herstellung neuer sekundärer Amine | |
| DE2211397C3 (fr) | ||
| DE2620777A1 (de) | Neue derivate des 1-hydroxy-benzo-2,3, 1-diazaborins und verfahren zu deren herstellung | |
| CH624963A5 (fr) | ||
| DE1470139C3 (de) | 5,11-Dihydrodibenz eckige Klammer auf b,e eckige Klammer zu-1,4-oxazepine und Verfahren zu ihrer Herstellung | |
| CH498854A (de) | Verfahren zur Herstellung von neuen Furazanderivaten | |
| DE2525962A1 (de) | Neue heterocyclische verbindungen, ihre herstellung und verwendung | |
| DE2533918A1 (de) | Neue derivate des 1-hydroxy-benzo- 2,3,1-diazaborins und verfahren zu deren herstellung | |
| DE2620776A1 (de) | Neue derivate des 1-hydroxy-benzo-2,3,1- diazaborins und verfahren zu deren herstellung | |
| AT369649B (de) | Verfahren zur bekaempfung von helminthenbefall bei haus- oder zuchttieren | |
| DE2306001C3 (de) | Pyrimidinderivate, Verfahren zu deren Herstellung und diese enthaltende Geflügelfutterzusammensetzungen | |
| DE1795053A1 (de) | Verfahren zur Herstellung von Verbindungen der Benzodiazepinreihe | |
| AT364836B (de) | Verfahren zur herstellung von neuen o-substituierten derivaten des (+)-cyanidan-3-ols und deren salzen | |
| AT203491B (de) | Verfahren zur Herstellung von neuen 3,5-Diketo-pyrazolidin-Derivaten | |
| AT330779B (de) | Verfahren zur herstellung von neuen chinolinessigsaurederivaten und ihren salzen | |
| AT256829B (de) | Verfahren zur Herstellung von neuen 2-Nitro-imidazolderivaten und deren Säureadditionssalzen | |
| DE1225658B (de) | Verfahren zur Herstellung von Cumarinderivaten | |
| CH602766A5 (en) | 10-Alpha-methoxy-di:hydro-beta-ergosine derivs. | |
| DE2948885A1 (de) | In 5 (6)-stellung substituierte benzimidazolcarbamate, verfahren und zwischenprodukte zu ihrer herstellung sowie ihre verwendung | |
| CH547281A (de) | Verfahren zur herstellung neuer oxindole. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |